Literature DB >> 10491286

Structural and functional characterization of the 5'-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene.

Y Hu1, J Hakkola, M Oscarson, M Ingelman-Sundberg.   

Abstract

Cytochrome P450 2E1 (CYP2E1) is a toxicologically very important enzyme with a high extent of interindividual variability in expression. We sequenced and characterized the 5'-flanking region of the human and rat CYP2E1 genes. The identity between the human and rat sequences (-3.8 kb to +1 kb) was generally between 35 and 60%, and the most similar regions were found in the proximal part of the sequence. Two more distant regions at -1.6 to -2.0 kb and -2.5 to -2. 8 kb in the human sequence were also found to have high identity to the rat sequence. A polymorphic repeat sequence in the human gene was found between -2178 to -1945 bp. The common allele (CYP2E1*1C) contained 6 repeats (each 42-60 bp long) and the rare allele (CYP2E1*1D) had 8 repeats with an allele frequency of 1% among Caucasians and 23% among Chinese. The CYP2E1 5'-flanking regions of the human (-3712 bp to +10 bp) and rat (-3685 bp to +28 bp) genes were ligated in front of a luciferase reporter gene and transfected into rat hepatoma Fao and human hepatoma B16A2 cells. Important species specificity was noted in the control of gene expression and regions of negative and positive cis-acting elements were localized. No difference was seen in the constitutive expression between the two polymorphic forms. The importance of this repeat polymorphism for high and low inducible CYP2E1 phenotypes is discussed. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491286     DOI: 10.1006/bbrc.1999.1362

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.

Authors:  S Liu; J Y Park; S P Schantz; J C Stern; P Lazarus
Journal:  Oral Oncol       Date:  2001-07       Impact factor: 5.337

Review 2.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.

Authors:  Hermann M Bolt; Peter H Roos; Ricarda Thier
Journal:  Int Arch Occup Environ Health       Date:  2003-03-01       Impact factor: 3.015

3.  Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study.

Authors:  Matthew W Linakis; Sarah F Cook; Shaun S Kumar; Xiaoxi Liu; Diana G Wilkins; Roger Gaedigk; Andrea Gaedigk; Catherine M T Sherwin; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

4.  Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.

Authors:  Cécile Gurnot; Ignacio Martin-Subero; Sarah M Mah; Whitney Weikum; Sarah J Goodman; Ursula Brain; Janet F Werker; Michael S Kobor; Manel Esteller; Tim F Oberlander; Takao K Hensch
Journal:  Epigenetics       Date:  2015-04-18       Impact factor: 4.528

5.  Cytochrome P450 2E1 high activity polymorphism in alcohol abuse and end-organ disease.

Authors:  Mark T Cartmell; Hans-Ulrich Schulz; Derek A O'Reilly; Bing-Mei Yang; Volker Kielstein; Simon P Dunlop; Walter Halangk; Andrew G Demaine; Andrew N Kingsnorth
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

6.  Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene.

Authors:  M-Y Lee; N Mukherjee; A J Pakstis; S Khaliq; A Mohyuddin; S Q Mehdi; W C Speed; J R Kidd; K K Kidd
Journal:  Pharmacogenomics J       Date:  2008-07-29       Impact factor: 3.550

7.  Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.

Authors:  Lena Ernstgård; Margareta Warholm; Gunnar Johanson
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

Review 8.  Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.

Authors:  Magnus Ingelman-Sundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-22       Impact factor: 3.000

9.  Relationship between genetic polymorphism of cytochrome P450IIE1 and fatty liver.

Authors:  Yun-Feng Piao; Jing-Tao Li; Yang Shi
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

10.  Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure.

Authors:  Michael H Court; Inga Peter; Suwagmani Hazarika; Magdalini Vasiadi; David J Greenblatt; William M Lee
Journal:  Drug Metab Dispos       Date:  2013-10-08       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.